Evotec’s White Paper Series: From Academic Concept to Commercial Reality: How to Accelerate Translational Drug Discovery

Published on : 14th February 2024

Discover more about the way-markers for a successful translational roadmap from the investor’s perspective

65LAB and Duke-NUS award US$1.85 million to combat chronic inflammation

Recipient Associate Professor Lena Ho spearheads groundbreaking research to develop first-in-class therapeutics to target inflammatory diseases Collaboration between 65LAB and Duke-NUS aims to advance

Biocentury: Singapore’s next challenge: turning momentum into sustainable growth

Read about the key role of 65LAB in Singapore’s burgeoning ecosystem, as it seeks to advance academic projects through the steps towards company formation.

Drug Discovery World Winter issue 2023/ 2024

Read DDW’s insights into whether AI can deliver better immunotherapies for cancer, and predictions on what to expect from the sector in 2024 Read